Special Feature| Volume 355, ISSUE 1, P3-5, January 2018

Cannabinoids and Symptomatic Bradycardia


      Cannabinoids, the bioactive components of marijuana, have adverse cardiovascular consequences, including symptomatic sinus bradycardia, sinus arrest and ventricular asystole. Physicians should be aware of these deleterious consequences which can appear in otherwise healthy persons who are chronic marijuana users.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bayewitch M.
        • Avidor-Reiss T.
        • Levy R.
        • et al.
        The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling.
        FEBS Lett. 1995; 375: 143-147
      1. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Drug Abuse Warning Network (DAWN), 2011. ICPSR34565-v3. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]. November 23, 2015.

        • Huestis M.A.
        Pharmacokinetics and metabolism of the plant cannabinoids, Δ9-tetrahydrocannabinol, cannabidiol and cannabinol.
        Handb Exp Pharmacol. 2005; : 657-690
        • Akins D.
        • Awdeh M.R.
        Marijuana and second-degree AV block.
        South Med J. 1981; 74: 371-373
        • Dockery B.K.
        • Newman K.P.
        Exercise-induced asystole with syncope in a healthy young man.
        Am J Med Sci. 2007; 334: 145-148
        • Jandhyala B.S.
        Effects of prolonged administration of delta 9-tetrahydrocannabinol on the autonomic and cardiovascular function and regional hemodynamics in mongrel dogs.
        Res Commun Chem Pathol Pharmacol. 1978; 20: 489-508
        • Benowitz N.L.
        • Jones R.T.
        Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
        Clin Pharmacol Ther. 1975; 18: 287-297
        • Benowitz N.L.
        • Jones R.T.
        Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man.
        J Clin Pharmacol. 1981; 21: 214S-223S
        • Jones R.T.
        Cardiovascular system effects of marijuana.
        J Clin Pharmacol. 2002; 42: 58S-63S
        • Smiley K.A.
        • Karler R.
        • Turkanis S.A.
        Effects of cannabinoids on the perfused rat heart.
        Res Commun Chem Pathol Pharmacol. 1976; 14: 659-675
        • Nahas G.
        • Trouve R.
        Effects and interactions of natural cannabinoids on the isolated heart.
        Proc Soc Exp Biol Med. 1985; 180: 312-316
        • Lake K.D.
        • Compton D.R.
        • Varga K.
        • et al.
        Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
        J Pharmacol Exp Ther. 1997; 281: 1030-1037
        • Matsuzaki M.
        • Casella G.A.
        • Ratner M.
        D9-Tetrahydrocannabinol: EEG changes, bradycardia and hypothermia in the rhesus monkey.
        Brain Res Bull. 1987; 19: 223-229
        • Niederhoffer N.
        • Szabo B.
        Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
        J Pharmacol Exp Ther. 2000; 294: 707-713